Schedule 13D ownership disclosure
aTyr Pharma Inc
Security class unavailable · CUSIP: 002120202
Event date: 2020-02-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 509,982
- Percent of class
- 5.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001564590-20-004724
- Form type
- SC 13D
- Filer
- SCHIMMEL PAUL
- CIK
- CIK 1236447
- Filed
- Feb 14, 2020
- Reporting period
- Feb 10, 2020
- Description
- Schedule 13D beneficial ownership